Latest News

Thursday, March 05, 2015 | Product Releases, Alcon

Alcon Releases Air Optix Colors Contact Lenses in Plus Powers for Patients with Hyperopia

Alcon has extended the line of Air Optix Colors contact lenses to include plus power lenses for patients with hyperopia across the full range of nine colors, according to a company news release. Ai…

Read the full story

Thursday, March 05, 2015 | Blindness, Second Sight Medical Products

Second Sight Announces Successful First Implants of the Argus II Retinal Prosthesis System at Two New Centers in Italy

Second Sight Medical Products announced that two newly approved centers, located in Camposampiero and Florence, have successfully completed their first commercial implants of the Argus II Retinal Pros…

Read the full story

Thursday, March 05, 2015 | Medical Studies

Wisdom Teeth Stem Cells Can Transform Into Cells that Could Treat Corneal Scarring

Stem cells from the dental pulp of wisdom teeth can be coaxed to turn into cells of the eye's cornea and could one day be used to repair corneal scarring due to infection or injury, according to r…

Read the full story

Wednesday, March 04, 2015 | Glaucoma

Neuroregeneration Research Promising for Glaucoma

Techniques for regenerating neurons damaged by glaucoma, which have had good results in animals, have improved vision in humans in a small preliminary trial. "We've made a lot of progress,&qu…

Read the full story

Wednesday, March 04, 2015 | Medical Studies

Injectable, 'Self-Healing' Hydrogel May Offer Simpler Form of Long-Term Drug Delivery

A new study published in Nature Communications reveals how scientists have created an injectable hydrogel that can deliver drugs over specific time periods, eliminating the surgical implantation requi…

Read the full story

Wednesday, March 04, 2015 | Medical Studies

Ocusoft Announces Positive Results from Dry Eye Study with Retaine

Ocusoft has announced the journal Clinical Ophthalmology has published positive results from a clinical investigation of their flagship dry eye product, Retaine, according to a company news rele…

Read the full story

Tuesday, March 03, 2015 | Management/Leadership, STAAR Surgical

Caren Mason Appointed President and CEO of Staar Surgical Company

Caren Mason has been named President and Chief Executive Officer os Staar Surgical Company effective immediately. Ms. Mason, who was elected to Staar's board of directors in June 2014,…

Read the full story

Tuesday, March 03, 2015 | Acquisitions/Mergers

Actavis Said to Begin Bond Offering to Back Allergan Deal

Actavis Plc started selling bonds in what may the biggest corporate debt deal in two years to finance its purchase of Botox-maker Allergan Inc. The drug company will issue the securities as soon as Tu…

Read the full story

Tuesday, March 03, 2015 | Glaucoma

Neuroregeneration Research Promising for Glaucoma

Techniques for regenerating neurons damaged by glaucoma, which have had good results in animals, have improved vision in humans in a small preliminary trial. "We've made a lot of progress,&qu…

Read the full story

Tuesday, March 03, 2015 | CE Mark Approval, Oraya Therapeutics

Oraya Therapeutics' AMD Radiotherapy Device Receives New Indication of Use for Choroidal Metastases

Oraya Therapeutics announced that the Oraya IRay Radiotherapy system has received a CE Mark extension for the treatment of choroidal metastases, a cancer in the eye, originating most commonly from pri…

Read the full story

Tuesday, March 03, 2015 | Medical Studies

Ranibizumab Reverses Vision Loss Caused by Diabetes

Ranibizumab, a prescription drug commonly used to treat age-related vision loss, also reverses vision loss caused by diabetes among Hispanic and non-Hispanic whites, according to a new study led by in…

Read the full story

Tuesday, March 03, 2015 | Management/Leadership

Michael Monteferrante Elected to Board of National Association for the Employment of People who are Blind

Michael Monteferrante, President and CEO of Envision, has been elected to the board of directors of the National Association for the Employment of People Who Are Blind (NAEPB). Monteferrante was also …

Read the full story

Monday, March 02, 2015 | Santen

EMA Accepts Santan's Marketing Application Filing for Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis of the Posterior Segment

Santen Pharmaceutical announced that the European Medicines Agency (EMA) has accepted the company’s marketing authorization application (MAA) filing for the use of intravitreal sirolimus, an inv…

Read the full story

Monday, March 02, 2015 | Clearside Biomedical

Clearside Biomedical Initiates Phase 2 Clinical Trial for Macular Edema Associated with Retinal Vein Occlusion Drug Candidate

Clearside Biomedical announced the enrollment of the first patient in a phase 2, randomized, controlled, masked, multicenter clinical trial for the treatment of macular edema associated with retinal v…

Read the full story

Monday, March 02, 2015 | Clinical Trials, Ohr Pharmaceutical

Ohr Pharmaceutical Announces Additional Positive Anatomic Data From the OHR-102 IMPACT Study Interim Analysis Presented at Annual Macula Society Meeting

Ohr Pharmaceutical announced the presentation of new data from the IMPACT study interim analysis at the 38th Annual Macula Society Meeting, which took place February 25-28, in Scottsdale, Arizona. The…

Read the full story
Load More